Ekso Bionics (EKSO)
(Real Time Quote from BATS)
$1.20 USD
-0.08 (-6.25%)
Updated Apr 26, 2024 01:32 PM ET
3-Hold of 5 3
C Value B Growth F Momentum D VGM
Price, Consensus and EPS Surprise
EKSO 1.20 -0.08(-6.25%)
Will EKSO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for EKSO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EKSO
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Here's Why Ekso Bionics (EKSO) Is a Great 'Buy the Bottom' Stock Now
EKSO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for January 31st
New Strong Buy Stocks for January 31st
Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates
Other News for EKSO
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
Ekso Bionics receives payment determination for medical reimbursement from CMS
Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session